Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.9 EUR | -1.52% | -1.02% | -13.72% |
Apr. 02 | Shedir Pharma, into 2023 with rising revenues; profit down single digits | AN |
Mar. 29 | Shedir Pharma Group S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 53.48M 57.77M | Sales 2023 | 59.39M 64.15M | Capitalization | 51.4M 55.52M |
---|---|---|---|---|---|
Net income 2022 | 5M 5.4M | Net income 2023 | 5M 5.4M | EV / Sales 2022 | 0.69 x |
Net cash position 2022 | 5.64M 6.1M | Net Debt 2023 | 7.26M 7.84M | EV / Sales 2023 | 0.99 x |
P/E ratio 2022 |
7.2
x | P/E ratio 2023 |
9.2
x | Employees | 79 |
Yield 2022 |
4.69% | Yield 2023 |
-
| Free-Float | 12.01% |
1 day | -1.52% | ||
1 week | -1.02% | ||
Current month | -1.02% | ||
1 month | +4.84% | ||
3 months | +0.52% | ||
6 months | -12.56% | ||
Current year | -13.72% |
Managers | Title | Age | Since |
---|---|---|---|
Antonio Scala
CEO | Chief Executive Officer | 39 | 13-12-31 |
Giuseppe Somma
IRC | Investor Relations Contact | - | 19-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marco Mazzarese
BRD | Director/Board Member | 46 | 18-12-31 |
Lucio Fusaro
BRD | Director/Board Member | 69 | 21-12-31 |
Umberto di Maio
FOU | Founder | 51 | 14-10-12 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 3.9 | -1.52% | 5 500 |
24-06-06 | 3.96 | 0.00% | 6,250 |
24-06-05 | 3.96 | +0.51% | 5,250 |
24-06-04 | 3.94 | 0.00% | 0 |
24-06-03 | 3.94 | 0.00% | 0 |
Real-time Borsa Italiana, June 07, 2024 at 11:44 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.72% | 48.96M | |
+46.41% | 754B | |
+40.95% | 630B | |
-5.67% | 352B | |
+19.88% | 331B | |
+9.32% | 298B | |
+18.45% | 250B | |
+11.88% | 217B | |
-0.78% | 216B | |
+6.46% | 164B |
- Stock Market
- Equities
- SHE Stock